References
- Amini A, Byers LA, Welsh JW, et al (2014). Progress in the management of limited-stage small cell lung cancer.Cancer, 120, 790-8. https://doi.org/10.1002/cncr.28505
- Brade AM, Tannock IF (2006). Scheduling of radiation and chemotherapy for limited-stage small-cell lung cancer: Repopulation as a cause of treatment failure? J Clin Oncol, 24, 1020-2. https://doi.org/10.1200/JCO.2005.04.9676
- Cai S, Shi A, Yu R, et al (2014). Feasibility of omitting clinical target volume for limited-disease small cell lung cancer treated with chemotherapy and intensity-modulated radiotherapy. Radiat Oncol, 9, 112-7. https://doi.org/10.1186/1748-717X-9-112
- Chen YT, Feng B, Chen LB (2012). Update of research on drug resistance in small cell lung cancer chemotherapy. Asian Pac J Cancer Prev, 13, 3577-81. https://doi.org/10.7314/APJCP.2012.13.8.3577
- Davis AJ, Tannock IF (2002). Tumor physiology and resistance to chemotherapy: repopulation and drug penetration. Cancer Treat Res, 112, 1-6. https://doi.org/10.1007/978-1-4615-1173-1_1
- De-Ruysscher D, Wanders S, Boersma L, et al (2004). A novel time factor, the SER (Start of any treatment and the End of Radiotherapy), is predictive for local control and survival in a systematic overview of combined chest radiotherapy and chemotherapy for limited stage small cell lung cancer. Radiother Oncol, 3, 143-9.
- De-Ruysscher D, Pijls-Johannesma M, Bentzen SM, et al (2006). Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. J Clin Oncol, 24, 1057-63. https://doi.org/10.1200/JCO.2005.02.9793
- De-Ruysscher D, Vansteenkiste J, Kester A, et al (2007). Timing of chest radiotherapy in patients with limited stage small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials. Cancer Treat Rev, 33, 461-73. https://doi.org/10.1016/j.ctrv.2007.03.002
- Feng ZX, Zhao LJ, Guan Y ,et al (2013). Metastatic characteristics of lymph node in supraclavicular zone and radiotherapy target volume for limited-stage small cell lung cancer.Zhonghua Yi Xue Za Zhi, 93,1476-8.
- Govindan R, Page N, Morgensztern D, et al (2006). Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol, 24, 4539-44. https://doi.org/10.1200/JCO.2005.04.4859
- Ha IB, Jeong BK, Jeong H, et al (2013). Effect of early chemoradiotherapy in patients with limited stage small cell lung cancer. Radiat Oncol J, 31, 185-90. https://doi.org/10.3857/roj.2013.31.4.185
- Han TJ, Kim HJ, Wu HG, et al (2012). Comparison of treatment outcomes between involved-field and elective nodal irradiation in limited-stage small cell lung cancer. Jpn J Clin Oncol, 42, 948-54. https://doi.org/10.1093/jjco/hys114
- Huncharek M, McGarry R (2004). A meta-analysis of the timing of chest irradiation in the combined modality treatment of limited-stage small cell lung cancer. Oncologist, 9, 665-72. https://doi.org/10.1634/theoncologist.9-6-665
- Jassem J ( 2007). The role of radiotherapy in lung cancer: where is the evidence? Radiother Oncol, 83, 203-13. https://doi.org/10.1016/j.radonc.2007.04.004
- Jeremic B, Shibamoto Y, Acimovic L, et al (2007). Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study. J Clin Oncol, 15, 893-900.
- Kalemkerian GP (2011). Advances in the treatment of small-cell lung cancer. Semin Respir Crit Care Med , 32, 94-101. https://doi.org/10.1055/s-0031-1272873
- Le-Pechoux C, Dunant A, Senan S, et al (2009). Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy: a randomised clinical trial. Lancet Oncol, 10, 467-74. https://doi.org/10.1016/S1470-2045(09)70101-9
- Manapov F, Klocking S, Niyazi M, et al (2013). Timing of failure in limited disease (stage I-III) small-cell lung cancer patients treated with chemoradiotherapy: a retrospective analysis. Tumori, 99, 656-60.
- Murray N, Coy P, Pater JL, et al (2003). Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. J Clin Oncol, 11, 336-44.
- Paumier A, Le Pechoux C (2010). Radiotherapy in small-cell lung cancer: where should it go? Lung Cancer, 69, 133-40. https://doi.org/10.1016/j.lungcan.2010.04.019
- Perry MC (2006). Thoracic radiation therapy in limited stage small-cell lung cancer: timing is everything. isn't it? J Clin Oncol, 24, 3815-6. https://doi.org/10.1200/JCO.2006.07.2827
- Simon GR, Turrisi A (2007). Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest, 132, 324-39. https://doi.org/10.1378/chest.07-1385
- Socinski MA, Bogart JA (2007). Limited-stage small-cell lung cancer: the current status of combined-modality therapy. J Clin Oncol, 25, 4137-45. https://doi.org/10.1200/JCO.2007.11.5303
- Spiro SG, James LE, Rudd RM, et al (2006). Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis. J Clin Oncol, 24, 3823-30. https://doi.org/10.1200/JCO.2005.05.3181
- Stinchcombe TE, Gore EM (2010). Limited-stage small cell lung cancer: current chemoradiotherapy treatment paradigms. Oncologist, 15, 187-9. https://doi.org/10.1634/theoncologist.2009-0298
- Tsujino K, Kurata T, Kawaguchi T, et al (2014). Role of consolidation chemotherapy after concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer. J Thorac Oncol, 9, 7-8 https://doi.org/10.1097/JTO.0000000000000028
- Viani GA, Boin AC, Ikeda VY, et al (2012). Thirty years of prophylactic cranial irradiation in patients with small cell lung cancer: a meta-analysis of randomized clinical trials. J Bras Pneumol, 38, 372-81. https://doi.org/10.1590/S1806-37132012000300013
- Wu BS, Hu Y, Sun J, et al (2014). Analysis on the characteristics and prognosis of pulmonary neuroendocrine tumors. Asian Pac J Cancer Prev, 15, 2205-10. https://doi.org/10.7314/APJCP.2014.15.5.2205
- Zhang J, Qi HW, Zheng H, et al (2014). Etoposide-cisplatin alternating with vinorelbine-cisplatin versus etoposide-Cisplatin alone in patients with extensive disease combined with small cell lung cancer. Asian Pac J Cancer Prev, 15, 4159-63. https://doi.org/10.7314/APJCP.2014.15.10.4159
Cited by
- Clinical features and prognostic factors of small cell lung cancer: A retrospective study in 148 patients vol.36, pp.6, 2016, https://doi.org/10.1007/s11596-016-1684-6